Spots Global Cancer Trial Database for observation
Every month we try and update this database with for observation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual Disease | NCT03770299 | Non-Small Cell ... Non-Small-Cell ... Circulating Tum... | Nivolumab Vinorelbine Gemcitabine Docetaxel Pemetrexed Cisplatin Carboplatin Paclitaxel Observation | 18 Years - | Bristol-Myers Squibb | |
| Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1) | NCT03199989 | Adjuvant Chemot... | CapeOX（Capecita... Observation | 18 Years - 75 Years | Peking University Cancer Hospital & Institute | |
| Clinical Characteristics of Lip Hemangiomas | NCT02351245 | Hemangioma | observation | - 2 Years | Zhujiang Hospital | |
| Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer. | NCT06126003 | Breast Cancer | Observation | 18 Years - 85 Years | BioCorteX Inc | |
| An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry | NCT02677961 | Neoplasms, Conn... Bone Neoplasms | Observation | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Cavity Boost Radiation Therapy vs. Observation in Cerebral Metastases After Complete Surgical Resection | NCT02887651 | Cerebral Metast... Surgery | Cavity boost ra... | 18 Years - | Heinrich-Heine University, Duesseldorf | |
| Predictive Assay for Decision Making in Adjuvant Therapy | NCT05032352 | Carcinoma, Non-... | Adjuvant Observation | 18 Years - | OncoCyte | |
| PROfiling Based Endometrial Cancer Adjuvant Therapy | NCT05179447 | Endometrial Can... Endometrial Can... | Vaginal brachyt... External beam r... Observation Chemoradiation ... | 18 Years - 75 Years | Women's Hospital School Of Medicine Zhejiang University | |
| Frailty Trajectories and Their Association With Health Outcomes | NCT05793229 | Frailty Syndrom... | observation | 60 Years - | Nanjing Medical University | |
| IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer | NCT00300586 | Stage IV Non-sm... | observation gemcitabine erlotinib | 18 Years - 70 Years | Hospices Civils de Lyon | |
| Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1) | NCT03199989 | Adjuvant Chemot... | CapeOX（Capecita... Observation | 18 Years - 75 Years | Peking University Cancer Hospital & Institute | |
| Study of Axitinib in Patients With Recurred or Metastatic Adenoid Cystic Carcinoma | NCT02859012 | Recurrent ACC, ... | Axitinib Observation | - | Seoul National University Hospital | |
| High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma | NCT00003641 | Melanoma (Skin) | interferon alfa... observation | 18 Years - | Eastern Cooperative Oncology Group | |
| Randomized Trial Comparing Radiosurgery With vs Without Whole Brain Radiotherapy | NCT00548756 | Brain Cancer | Whole Brain Rad... Observation Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Influence of Positive Margins on Tumour Recurrence and Overall Survival After Gastrectomy for Gastric Cancer | NCT04439812 | Stomach Neoplas... | Observation | - | Hospital Universitario Ramon y Cajal | |
| Comparative Study of Janus Kinase (JAK) Inhibitors Vs Tumor Necrosis Factor (TNF) Inhibitors in Rheumatoid Arthritis | NCT05567380 | Rheumatoid Arth... | Observation | 18 Years - | Sohag University | |
| Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy | NCT04085250 | Stage III Non-s... | Neoadjuvant the... Chemotherapy co... Radiotherapy Nivolumab Observation | 18 Years - 75 Years | Sun Yat-sen University | |
| Chemotherapy With or Without Radiosurgery for Asymptomatic Oligo Brain Metastasis | NCT01301560 | Nonsmall Cell L... | Radiosurgery Observation | 18 Years - | Samsung Medical Center | |
| Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism | NCT02001051 | Subclinical Hyp... Cushing Syndrom... Adrenal Neoplas... | Adrenalectomy Observation | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Incidence of Refeeding Syndrome in Consecutively Admitted Patients | NCT05967858 | Refeeding Syndr... Starvation Phosphate Defic... | observation | 18 Years - | University of Copenhagen | |
| GU-01: Glycyrrhizin in Prostate Cancer | NCT06378346 | Prostate Cancer | Glycyrrhizin Glycyrrhizin Observation | 18 Years - | University of Illinois at Chicago | |
| A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor. | NCT05717166 | Metastatic Tumo... | Palliative Radi... Chemotherapy Hormone therapy Immunotherapy Targeted System... Observation Stereotactic Ab... Surgery Radiofrequency ... Fractionated Ra... | 18 Years - | Lawson Health Research Institute | |
| Retrospective Evaluation of Commercial Spacers in Prostate Cancer Patients | NCT05354427 | Prostate Cancer | Observation | 18 Years - | BioProtect | |
| Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial) | NCT02595944 | Stage IB Lung N... Stage II Lung N... Stage IIIA Lung... | Biospecimen Col... Computed Tomogr... Echocardiograph... Nivolumab Observation Positron Emissi... | 18 Years - | National Cancer Institute (NCI) | |
| Treatments and Outcomes of Untreated Cerebral Cavernous Malformations in CHina. | NCT03467295 | Cerebral Cavern... | Surgery Observation | - | First Affiliated Hospital of Fujian Medical University | |
| Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Cancer | NCT00947102 | Pancreatic Tubu... | Observation | 30 Years - 85 Years | Blood Transfusion Centre of Slovenia | |
| Outcomes of Unfit Patients With CLL Included in the GIMEMA LLC1114 Trial Who Discontinued Ibrutinib Due to Reasons Other Than Disease Progression | NCT06084923 | Chronic Lymphoc... | Observation | 18 Years - | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer | NCT05601440 | Breast Cancer | RP-6306 Gemcitabine Observation Niraparib Fulvestrant | - | Canadian Cancer Trials Group | |
| Prostate Cancer Biobank | NCT04024475 | Prostatic Neopl... | Observation | 18 Years - 70 Years | Swiss Group for Clinical Cancer Research | |
| Metronomic Capecitabine in Stage III Gastric Cancer | NCT06313567 | Gastric Cancer | Metronomic cape... Observation | 18 Years - 80 Years | Fudan University | |
| Incidence of Refeeding Syndrome in Consecutively Admitted Patients | NCT05967858 | Refeeding Syndr... Starvation Phosphate Defic... | observation | 18 Years - | University of Copenhagen | |
| Maintenance Treatment With S-1 in Gastric Cancer Patients | NCT03701373 | Gastric Cancer ... Cancer of Stoma... | S-1 maintenance Observation | 18 Years - 80 Years | Sun Yat-sen University | |
| Treatments and Outcomes of Untreated Cerebral Cavernous Malformations in CHina. | NCT03467295 | Cerebral Cavern... | Surgery Observation | - | First Affiliated Hospital of Fujian Medical University | |
| Testing The Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia | NCT03737981 | Chronic Lymphoc... Small Lymphocyt... | Ibrutinib Obinutuzumab Observation Venetoclax | 65 Years - | National Cancer Institute (NCI) | |
| Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder Cancer | NCT04333927 | Biliary Tract C... Extrahepatic Ch... Gallbladder Can... | Chemotherapy Observation Immunotherapy Radiotherapy | 18 Years - 70 Years | Sun Yat-sen University | |
| Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes | NCT00809575 | Adult Myelodysplastic... | questionnaire a... fatigue assessm... observation quality-of-life... | 18 Years - | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma | NCT01599559 | Primary Mediast... | observation 3D-Conformal Ra... | 18 Years - | International Extranodal Lymphoma Study Group (IELSG) | |
| Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer | NCT03503799 | Primary Invasiv... Estrogen Recept... Human Epidermal... | Observation | 18 Years - | North Eastern German Society of Gynaecological Oncology | |
| Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) | NCT00075829 | Multiple Myelom... | One Autologous ... Non-Myeloablati... Second Autologo... Thalidomide Dexamethasone Observation | - 70 Years | National Heart, Lung, and Blood Institute (NHLBI) | |
| Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy | NCT04085250 | Stage III Non-s... | Neoadjuvant the... Chemotherapy co... Radiotherapy Nivolumab Observation | 18 Years - 75 Years | Sun Yat-sen University | |
| Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer | NCT00048997 | Lung Cancer | Radiation thera... Observation | 18 Years - | Radiation Therapy Oncology Group | |
| Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure | NCT04442048 | Cancer Covid-19 | IMM-101 Observation | 18 Years - | Canadian Cancer Trials Group | |
| Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular Carcinoma | NCT02109146 | Hepatocellular ... Transcatheter A... | Prophylactic Tr... Observation | 18 Years - 80 Years | Zhejiang University | |
| Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and IV Melanoma Patients. | NCT02718391 | Malignant Melan... Adjuvant Drug T... Vaccin Therapy | Autologous Dend... | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| Current Management of Gastrointestinal Stromal Tumors (GIST) in the Region of Coquimbo | NCT00564265 | Gastrointestina... | Observation | 15 Years - | Cirujanos la Serena | |
| Prostate Cancer Biobank | NCT04024475 | Prostatic Neopl... | Observation | 18 Years - 70 Years | Swiss Group for Clinical Cancer Research | |
| Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer | NCT03503799 | Primary Invasiv... Estrogen Recept... Human Epidermal... | Observation | 18 Years - | North Eastern German Society of Gynaecological Oncology | |
| Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis | NCT02285738 | Solid Tumor Cancer | Aspirin Simvastatin Observation | 18 Years - | Case Comprehensive Cancer Center | |
| Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas | NCT05433935 | Intraductal Pap... | Observation | 0 Years - 90 Years | Zhejiang University | |
| Tumor Registry of Advanced Renal Cell Carcinoma | NCT00610012 | Renal Cell Carc... | 18 Years - | iOMEDICO AG | ||
| Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors | NCT03721341 | Metastatic Tumo... | Palliative Radi... Chemotherapy Immunotherapy Hormones Observation Stereotactic Ab... | 18 Years - | Lawson Health Research Institute | |
| An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry | NCT02677961 | Neoplasms, Conn... Bone Neoplasms | Observation | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Maintenance Treatment Versus Observation After Induction in Advanced Colorectal Carcinoma | NCT00442637 | Colorectal Canc... | capecitabine + ... observation | 18 Years - | Dutch Colorectal Cancer Group | |
| Automated Segmentation and Volumetry for Meningioma Using Deep Learning | NCT05093751 | Meningioma Artificial Inte... | Observation | 18 Years - | Seoul National University Hospital | |
| Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer | NCT01244789 | Endometrial Can... | carboplatin and... observation | 18 Years - | Danish Gynecological Cancer Group | |
| Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT02085408 | Acute Myeloid L... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Secondary Acute... Untreated Adult... | Daunorubicin Cytarabine Clofarabine Decitabine Observation Allogeneic hema... | 60 Years - | Eastern Cooperative Oncology Group | |
| Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei | NCT01946854 | Gastrointestina... | Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| PROfiling Based Endometrial Cancer Adjuvant Therapy | NCT05179447 | Endometrial Can... Endometrial Can... | Vaginal brachyt... External beam r... Observation Chemoradiation ... | 18 Years - 75 Years | Women's Hospital School Of Medicine Zhejiang University | |
| Thalidomide Maintenance Treatment in DLBCL | NCT03016000 | Lymphoma, Large... | Thalidomide Observation | 18 Years - 60 Years | Nanfang Hospital, Southern Medical University | |
| Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-Small Cell Lung Cancer, ALCHEMIST Trial | NCT04267848 | Lung Non-Small ... Lung Non-Small ... Lung Non-Squamo... Stage II Lung C... Stage IIIA Lung... Stage IIIB Lung... | Biospecimen Col... Carboplatin Cisplatin Computed Tomogr... Echocardiograph... Gemcitabine Hyd... Magnetic Resona... Observation Paclitaxel Pembrolizumab Pemetrexed Diso... Quality-of-Life... Questionnaire A... | 18 Years - | National Cancer Institute (NCI) | |
| Postmenopausal Women With Vaginal Microbiota | NCT03786601 | HPV-Related Squ... | Observation | 20 Years - 75 Years | Peking Union Medical College Hospital | |
| PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery | NCT05468138 | MSI-H PD-1 Immunother... Gastric Cancer Adjuvant Therap... | SOX XELOX Observation PD-1 antibody | 18 Years - 75 Years | Fudan University | |
| S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML | NCT00085709 | Leukemia | gemtuzumab ozog... observation Cytosine arabin... Daunomycin | 18 Years - 60 Years | SWOG Cancer Research Network | |
| Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis | NCT00004196 | Melanoma (Skin) | recombinant int... lymphangiograph... Observation | 18 Years - 70 Years | University of Alabama at Birmingham | |
| Metronomic Capecitabine in Stage III Gastric Cancer | NCT06313567 | Gastric Cancer | Metronomic cape... Observation | 18 Years - 80 Years | Fudan University | |
| Postmenopausal Women With Vaginal Microbiota | NCT03786601 | HPV-Related Squ... | Observation | 20 Years - 75 Years | Peking Union Medical College Hospital | |
| Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer | NCT01244789 | Endometrial Can... | carboplatin and... observation | 18 Years - | Danish Gynecological Cancer Group | |
| Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions | NCT05524389 | Endometrial Can... Adjuvant Radiot... Molecular Class... | Vaginal brachyt... Pelvic external... Observation Chemotherapy | 18 Years - 75 Years | Peking Union Medical College Hospital | |
| Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure | NCT04442048 | Cancer Covid-19 | IMM-101 Observation | 18 Years - | Canadian Cancer Trials Group | |
| Feasibility Study: Comparison of Performance Status With Objective Physical Activity Monitors | NCT01063400 | Non Small Cell ... | Observation | 18 Years - | University of Wisconsin, Madison | |
| Complete Decongestive Therapy on Head and Neck Lymphedema | NCT04045860 | Lymphedema of F... Secondary Lymph... | Complete Decong... Observation | 18 Years - | Our Lady of the Lake Hospital | |
| Neurotropic Melanoma of the Head and Neck | NCT00975520 | Melanoma | Observation Radiation Thera... | 18 Years - | Melanoma and Skin Cancer Trials Limited | |
| Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2 | NCT04229979 | Acute Myeloid L... | Galinpepimut-S Azacitidine Venetoclax Decitabine Cytarabine Observation GM-CSF Montanide | 18 Years - | Sellas Life Sciences Group | |
| Watchful Waiting. An Observational Study of Patients With Rectal Cancer After Concomitant Radiation and Chemotherapy | NCT00952926 | Rectal Cancer | 18 Years - | Vejle Hospital | ||
| The AIM Study: Assessing the Impact of Margin Reduction | NCT00754000 | Prostate Cancer | Observation | 18 Years - | Varian, a Siemens Healthineers Company | |
| Comparative Study of Janus Kinase (JAK) Inhibitors Vs Tumor Necrosis Factor (TNF) Inhibitors in Rheumatoid Arthritis | NCT05567380 | Rheumatoid Arth... | Observation | 18 Years - | Sohag University | |
| Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT02085408 | Acute Myeloid L... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Secondary Acute... Untreated Adult... | Daunorubicin Cytarabine Clofarabine Decitabine Observation Allogeneic hema... | 60 Years - | Eastern Cooperative Oncology Group | |
| IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer | NCT00300586 | Stage IV Non-sm... | observation gemcitabine erlotinib | 18 Years - 70 Years | Hospices Civils de Lyon | |
| A Retrospective Protocol Empowering Precision Research in Colorectal Cancer (ALFAOMEGA-RETRÒ) | NCT05101382 | Colorectal Canc... | Observation | 18 Years - | IFOM ETS - The AIRC Institute of Molecular Oncology | |
| Frailty Trajectories and Their Association With Health Outcomes | NCT05793229 | Frailty Syndrom... | observation | 60 Years - | Nanjing Medical University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
